ExploreWatchlistsPricing
  1. JP-listed companies
  2. Fuji Pharma Co.,Ltd.
  3. Financials
  4. Marketable securities, non-current

Fuji Pharma Co.,Ltd. (4554)

Market cap
¥61.9B
P/E ratio
27.2x
Develops and manufactures specialized injectable medications for hospitals and medical distributors, focusing on hormone treatments and medical imaging contrast agents.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndMarketable securities, non-current (Million JPY)YoY (%)
Sep 30, 20255,094-28.17%
Sep 30, 20247,092-33.01%
Sep 30, 202310,587+44.26%
Sep 30, 20227,339-5.45%
Sep 30, 20217,762+10.89%
Sep 30, 20207,000-4.66%
Sep 30, 20197,342+12136.67%
Sep 30, 201860+3.45%
Sep 30, 201758-54.69%
Sep 30, 2016128+18.52%
Sep 30, 2015108+16.13%
Sep 30, 201493

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat